Question 14897 — diseases

Summary

Mr. Vincent Trébuchet draws the attention of the Minister of Health, Families, Autonomy and People with Disabilities to the still insufficient recognition and treatment of Lewy body disease (MCL) in France. This neurodegenerative disease, less known than Alzheimer's disease or Parkinson's disease, nevertheless constitutes one of the main causes of major neurocognitive disorders. It would affect, according to estimates available, between 200,000 and 250,000 people in France. Despite this high prevalence, it remains very insufficiently identified: almost two thirds of patients are not diagnosed or do not benefit from appropriate care. In the Ardèche department in particular, several families have recently been confronted with deaths linked to this pathology. These situations highlighted the fact that fault with a sufficiently early diagnosis and a clearly identified care pathway, relatives often find themselves alone to support patients suffering from particularly severe cognitive, motor, psychiatric or behavioral disorders. They then become de facto caregivers, without sufficient training and without specific support. Lewy body disease presents complex, sometimes fluctuating symptoms, notably associating cognitive disorders, hallucinations, sleep disorders, motor disorders similar to those observed in Parkinson's disease, as well as a great sensitivity to certain treatments. This complexity favors errors or delays in diagnosis, with significant consequences on the quality of life of patients, on medical and medico-social orientation, but also on the exhaustion of caregivers. But the doctors General practitioners are often the first professionals likely to spot warning signs and refer patients to memory consultations, neurologists, geriatricians or specialized centers. However, Lewy body disease still remains insufficiently present in the initial and continuing training of health professionals. This insufficient dissemination of knowledge contributes to wandering diagnosis and unequal care depending on the territory, particularly in rural departments where access to specialists is already more difficult. This situation more broadly raises the question of the place given to Lewy body disease in public policies relating to neurodegenerative diseases. While there is currently no curative treatment, earlier diagnosis would nevertheless allow to adapt care, avoid certain inappropriate prescriptions, organize medical-social support more quickly and better support caregivers. Also, he asks what measures the Government intends to take to improve the recognition of Lewy body disease, strengthen its place in the initial and continuing training of doctors, particularly general practitioners, and support research into this pathology and put in place specific support for patients and their caregivers.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.